SCHEMBL20006073

SCHEMBL20006073

Cc1cc(Cl)ccc1OCCCOc1ccccc1Cl

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.60
L3MBTL1 Q9Y468 6/20 0.60
RAB9A P51151 5/20 0.60
NPC1 O15118 4/20 0.60
HPGD P15428 4/20 0.60
CYP1A2 P05177 2/20 0.60
CYP3A4 P08684 2/20 0.60
CYP2C19 P33261 2/20 0.60
CYP2C9 P11712 1/20 0.60
SMN1; SMN2 Q16637 1/20 0.60
ATM Q13315 1/20 0.54
KDM4E B2RXH2 1/20 0.54
TP53 P04637 1/20 0.54
ALOX15 P16050 1/20 0.54
ALDH1A1 P00352 1/20 0.52
SCN4A P35499 2/20 0.51
S1PR4 O95977 1/20 0.50
TDP1 Q9NUW8 1/20 0.50
MEN1 O00255 2/20 0.49
KMT2A Q03164 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20005629 0.85 SCN4A (0.55) MAPTL3MBTL1RAB9ANPC1HPGD
SCHEMBL22135588 0.84 KDM4E (0.64) MAPTRAB9ANPC1HPGDCYP1A2
SCHEMBL8347835 0.80 KDM4E (0.59) MAPTL3MBTL1RAB9ANPC1HPGD
SCHEMBL5290296 0.79 L3MBTL1 (0.61) MAPTL3MBTL1RAB9ANPC1HPGD
SCHEMBL15869672 0.79 SCN4A (0.56) MAPTRAB9ANPC1HPGDKDM4E
SCHEMBL25261375 0.78 KDM4E (0.61) MAPTRAB9ANPC1HPGDCYP1A2
SCHEMBL8234481 0.78 KDM4E (0.56) MAPTL3MBTL1RAB9ANPC1HPGD
SCHEMBL14015785 0.77 KDM4E (0.56) MAPTRAB9ANPC1HPGDCYP1A2
SCHEMBL8295970 0.76 KDM4E (0.59) MAPTRAB9ANPC1HPGDCYP1A2
SCHEMBL3525710 0.76 ALDH1A1 (0.57) MAPTRAB9ANPC1HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10501413-B2 Inhibitors of the Notch transcriptional activation complex and methods for use of the same UNIVERSITY OF MIAMI (US) 2019-12-10 US disclosed
US-20180086700-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2018-03-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10501413-B2 Inhibitors of the Notch transcriptional activation complex and methods for use of the same NOTCH1, CBFB, HES1 MAPT 3938/4885L3MBTL1 805/4885RAB9A 3454/4885
US-20180086700-A1 INHIBITORS OF THE NOTCH TRANSCRIPTIONAL ACTIVATION COMPLEX AND METHODS FOR USE OF THE SAME NOTCH1, CBFB, HES1 MAPT 3938/4885L3MBTL1 805/4885RAB9A 3454/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.